Fortrea Denmark ApS: Financial statements 2021
CVR: 35240446
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Fortrea Denmark ApS (CVR 35240446) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 38,944,351 and a net result of DKK 2,697,754 compared with DKK 3,019,056 the year before. That is a decrease of 3.7% compared with the year before. Equity in the 2021 report amounted to DKK 2,937,705. The solvency ratio was 41.2%. The company had 43 employees in the financial year.
- Gross Profit
- DKK 38,944,351
- Profit/Loss
- DKK 2,697,754
- Equity
- DKK 2,937,705
- Total Assets
- DKK 7,130,097
- Employees
- 43
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 38.9 mio. | 2.7 mio. | 2.9 mio. | 43 |
| 2020 | - | 40.4 mio. | 3 mio. | 10.7 mio. | 46 |
| 2019 | - | 35.9 mio. | 2.5 mio. | 7.7 mio. | 43 |
| 2018 | - | 34.4 mio. | 2.5 mio. | 5.2 mio. | 41 |
| 2017 | - | 33.7 mio. | 2.6 mio. | 10.7 mio. | 40 |
Official annual report
Find more companies like Fortrea Denmark ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
On June 25, 2021, the company changed its name from COVANCE DENMARK ApS to Labcorp Clinical Development ApS.
Fortrea Denmark ApS has published its annual report for 2020. Gross profit came to DKK 40,435,500, and the net result was DKK 3,019,056.
About Fortrea Denmark ApS
Fortrea Denmark ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Labcorp Clinical Development ApS and COVANCE DENMARK ApS. The management consists of Agnieszka Moskal Gallagher. The company is owned by Fortrea Development Ltd.. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 29,191,545 and a net result of DKK 1,739,960 compared with DKK 688,702 the year before. Equity in the 2025 report amounted to DKK 10,187,341.